Romiplostim as a Viable and Long-term Remedy for Refractory Immune Thrombocytopenia and Concomitant Small B-Cell Lymphoma

Authors :: Jeremy Pantin
Charles Todd Bruker
Paul M. Dainer
Nathan Ryan
Germame Ajebo
Source :: Journal of Blood & Lymph. 9
Publication Year :: 2019
Publisher :: Hilaris SRL, 2019.

Subjects :: Romiplostim
Refractory
business.industry
Concomitant
Immunology
Medicine
business
B-cell lymphoma
medicine.disease
Immune thrombocytopenia
medicine.drug

Tools